Drug Discovery & Development

Drug Discovery & Development

Basilea to collaborate with US biotech to develop new antifungal drug

Basilea Pharmaceutica is continuing its quest to develop much-needed new antifungal drugs by penning a deal with Prokaryotics.  The collaboration will see Switzerland-based Basilea and...
Read more
Drug Discovery & Development

Kazia Therapeutics announces compelling preclinical and translational data for nuclear PD-L1 degrader (NDL2)

Kazia Therapeutics, an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, has announced compelling preclinical and translational data supporting the development of NDL2,...
Read more
Drug Discovery & Development

Mammoth Biosciences announces new results on NanoCas – the first efficient ultracompact extrahepatic gene editor

Mammoth Biosciences, a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new preclinical research,...
Read more
Drug Discovery & Development

Samsung Biologics expands US manufacturing capacity with acquisition from GSK

Samsung Biologics has announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100% of Human...
Read more
Drug Discovery & Development

Two-part white paper introduces pharma R&D through AI

ACD/Labs, an informatics company that develops and commercialises software in support of digitalised R&D, has announced the release of a new two-part white paper...
Read more

New deal to expand immune portfolio

Biogen has struck a deal with a new biotechnology company launched by Versant Ventures, for the research and development of experimental drugs for immune conditions. The deal...
Read more
Discovery

Powerful new antibiotic class to tackle new deadly superbugs discovered

Scientists at the University of Liverpool, working with international collaborators, have discovered Novltex, a groundbreaking new class of antibiotics with potent activity against some...
Read more

Pioneering iPSC research and in vivo data for treatment of Parkinson’s Disease

BrainXell, Inc. presented data during poster sessions at the 2025 Society for Neuroscience (SfN) Annual Meeting in San Diego this month, highlighting new breakthroughs...
Read more
- Advertisement -spot_img
- Advertisement -
EPO Summit ad
- Advertisement -
Pharmconex ad
- Advertisement -
NLS Days ad
- Advertisement -
ILMAC ad
- Advertisement -
BIO Europe

Latest posts

Load more

Drug Discovery & Development (DDD) is dedicated to advancing scientific innovations into active medical solutions. Its aim is to accelerate breakthroughs in medicine, addressing human disease and improving global health outcomes.

Menu

© Web design by Social Media Services 2026. All rights reserved.